Colon cancer chemopreventive drugs modulate integrin-mediated signaling pathways

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 949-956

  Weyant, Michael J ^a   Carothers, Adelaide M ^a   Bertagnolli, Maria E ^b   Bertagnolli, Monica M ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b GONZAGA UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIOXIDANT; CAFFEIC ACID DERIVATIVE; ESTER DERIVATIVE; FOCAL ADHESION KINASE; INTEGRIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPHENOL DERIVATIVE; PROTEIN P130; SULINDAC SULFIDE;

APOPTOSIS; ARTICLE; CANCER INCIDENCE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACTINS; ANTINEOPLASTIC AGENTS; CAFFEIC ACIDS; CELL MOVEMENT; COLONIC NEOPLASMS; CRK-ASSOCIATED SUBSTRATE PROTEIN; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRINS; PHENYLETHYL ALCOHOL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEINS; RETINOBLASTOMA-LIKE PROTEIN P130; SIGNAL TRANSDUCTION; SULINDAC; TUMOR CELLS, CULTURED;

EID: 0034064672     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Ruoslahti, E. Fibronectin and its integrin receptors in cancer. Adv. Cancer Res., 76: 1-20, 1999.
2. Hynes, R. O. Integrins: versatility, modulation and signaling in cell adhesion. Cell, 69: 11-25, 1992.
3. Sastry, S., and Horwitz, A. Integrin cytoplasmic domains: mediators of cytoskeletal linkage and extra- and intracellular initiated transmembrane signalling. Curr. Opin. Cell Biol., 5: 819-831, 1993.
4. Clark, E. A., and Brugge, J. S. Integrins and signal transduction pathways: the road taken. Science (Washington DC), 268: 233-239, 1995.
5. Hungerford, J. E., Compton, M. T., Matter, M. L., Hoffstrom, B. G., and Otey, C. J. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J. Cell Biol., 135: 1383-1390, 1996.
6. Xu, L., Owens, L. V., Sturge, G. C., Yang, X., Liu, E. T., Craven, R. J., and Cance, W. G. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ., 7, 413-418, 1996.
7. Ilic, D., Ameida, E. A., Schlaepfer, D. D., Dazin, P., Aizawa, S., and Damsky, C. H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol., 143: 547-560, 1998.
8. Frisch, S. M., Vuori, K., Ruoslahti, E., and Chan-Hui, P-Y. A role for Jun-N-terminal kinase in anoikis: suppression by bcl-2 and crmA. J. Cell Biol., 134: 793-399, 1996.
9. Gilmore, A. P., and Romer, L. H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell, 7: 1209-1224, 1996.
10. Zhao, J-H., Reiske, H., and Guan, J-L. Regulation of the cell cycle by focal adhesion kinase. J. Cell Biol., 143: 1997-2008, 1998.
11. 1 phase of the cell cycle. J. Cell Biol., 145: 1461-1469, 1999.
12. Richardson, A., and Parsons, J. T. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature (Lond.), 380: 538-540, 1996.
13. Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Normura, S., Fujimoto, J., Okada, M., Yamamoto, T., and Aizawa, S. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (Lond.), 377: 539-543, 1995.
14. Cary, L. A., Chang, J. F., and Guan, J-L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci., 109: 1787-1794, 1996.
15. Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, F. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (Lond.), 372: 786-791, 1994.
16. Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol., 140: 211-221, 1998.
17. Cas Proc. Natl. Acad. Sci. USA, 92: 10678-10682, 1995.
18. Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J. Biol. Chem., 271: 13649-13655, 1996.
19. Vuori, K., Hirai, H., Aizawa, S., and Ruoslahti, E. Introduction of p130Cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol. Cell. Biol., 16: 2606-2613, 1996.
20. Brown, M. C., Perotta, J. A., and Turner, C. E. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J. Cell Biol., 135: 1109-1123, 1996.
21. Schaller, M. D., and Parsons, J. T. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol. Cell. Biol., 15: 2635-2645, 1995.
22. Chen, H-C., Appeddu, P. A., Parsons, J. T., Hildebrand, J. D., Schaller, M. D., and Guan, J-L. Interaction of focal adhesion kinase with cytoskeleton protein talin. J. Biol. Chem., 270: 16995-16999, 1995.
23. Weiner, T. M., Liu, E. T., Craven, R. J., and Cance, W. G. Expression of focal adhesion kinase gene and invasive cancer. Lancet, 342: 1024-1025, 1993.
24. Withers, B. E., Hanks, S. K., and Fry, D. W. Correlation between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells. Cancer Biochem. Biophys., 15: 127-139, 1996.
25. Brunton, V. G., Ozanne, B. W., Paraskeva, C., and Frame, M. C. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene, 14: 283-293, 1997.
26. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martuccin, C., Guo, X. J., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
27. Mahmoud, N. N., Boolbol, S. K., Dannenberg, A. J., Mestre, J. R., Bilinski, R. T., Martucci, C., Newmark, H. L., Chadburn, A., and Bertagnolli, M. M. The sulindac metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis (Lond.), 19: 87-91, 1998.
28. Mahmoud, N. N., Carothers, A. M., Grunberger, D., Bilinski, R. T., Churchill, M. R., Martucci, C., Newmark, H. L., and Bertagnolli, M. M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis, in press, 2000.
29. Frisch, S. M., and Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol., 9: 701-706, 1997.
30. Piazza, G. A., Rahm, A. K., Finn, T. S., Fryer, B. H., Li, H., Stoumen, A. L., Pamukcu, R., and Ahnen, D. J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res., 57: 2452-2459, 1997.
31. Samaha, H. S., Kelloff, G. J., Steele, V., Rao, C. V., and Reddy, B. S. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptosis index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57: 1301-1305, 1997.
32. Chan, T. A., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mechanism underlying nonsteroidal antiinflammatory drug-induced apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-686, 1998.
33. Reddy, B. S., Kawamori, T., Lubet, R. A., Steele, V. E., Kelloff, G. J., and Rao, C. V. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res., 59: 3387-3391, 1999.
34. Mahmoud, N. N., Kucherlapati, R., Bilinski, R. T., Churchill, M. R., Chadburn, A., and Bertagnolli, M. M. Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. Cancer Res., 59: 353-359, 1999.
35. Tsujji, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
36. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
37. Grunberger, D., Banerjee, R., Eisinger, K., Oltz, E., Efros, L., Caldwell, M., Estevez, V., and Nakanishi, K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia (Basel), 44: 230-232, 1988.
38. Huang, J., Papadopoulos, N., McKinley, A. J., Farrington, S. M., Curtis, L. J., Wyllie, A. H., Zheng, S., Willson, J. K., Markowitz, S. D., Morin, P., Kinzler, K., Vogelstein, B., and Dunlop, M. G. APC mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. USA, 93: 9049-9054, 1996.
39. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
40. Smith, K. J., Johnson, K. A., Bryan, T. M., Hill, D. E., Markowitz, S., Willson, J. K., Paraskeva, C., Petersen, G. M., Hamilton, S. R., Vogelstein, B., et al. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA, 90: 2846-2850, 1993.
41. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
42. Sparks, A. B., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58: 1130-1134, 1998.
43. Yoshikawa, H., Nagashima, M., Khan, M. A., McMenamin, M. G., Hagiwara, K., and Harris, C. C. Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene, 18: 3415-3421, 1999.
44. Brancolini, C., Lazarevic, D., Rodrigues, J., and Schneider, C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of β-catenin. J. Cell Biol., 139: 759-771, 1997.
45. Retta, S. F., Barry, S. T., Critchley, D. R., Defilippi, P., Silengo, L., and Tarone, G. Focal adhesion and stress fiber formation is regulated by tyrosine phosphatase activity. Exp. Cell Res., 229: 307-317, 1996.
46. Clark, E. A., King, W. G., Brugge, J. S., Symons, M., and Hynes, R. O. Integrin-mediated signals regulated by members of the rho family of GTPases. J. Cell Biol., 142: 573-586, 1998.
47. Chrzanowska-Wodnicka, M., and Burridge, K. Tyrosine phosphorylation is involved in reorganization of the actin cytoskeleton in response to serum or LPA stimulation. J. Cell Sci., 107: 3643-3654, 1994.
48. Block, G., Patterson, B., and Subar, A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer, 18: 1-29, 1992.
49. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333: 609-614, 1995.
50. Bertagnolli, M. M. Apc and intestinal tumorigenesis: insights from animal models. Ann. NY Acad. Sci., in press, 2000.
51. Bergan, R., Kyle, E., Nguyen, P., Trepel, J., Ingui, C., and Neckers, L. Genistein-stimulated adherence of prostate cancer cells is associated with enhanced binding of focal adhesion kinase to β-1-integrin. Clin. Exp. Metastasis, 14: 389-398, 1996.
52. Rao, C. V., Wang, C. X., Simi, B., Lubet, R., Kelloff, G., Steele, V., and Reddy, B. S. Enhancement of experimental colon cancer by genistein. Cancer Res., 57; 3717-3722, 1997.
53. Zheng, Z. S., Xue, G. Z., Grunberger, D., and Prystowsky, J. Caffeic acid phenethyl ester inhibits proliferation of human keratinocytes and interferes with the EGF regulation of ornithine decarboxylase. Oncol. Res., 7: 445-452, 1995.
54. Fournier, D. B., Erdman, J. W., Jr., and Gordon, G. B. Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data. Cancer Epidemiol. Biomark. Prev., 7: 1055-1065, 1998.
55. Winde, G., Lugering, N., Glodny, B., Schmid, K. W., Muller, O., Senninger, N., and Osswald, H. Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention. Cancer Lett., 134: 201-207, 1998.
56. Sorensen, I. K., Kristiansen, E., Mortensen, A., Nicolaisen, G. M., Wijnands, J. A., van Kranen, H. J., and van Kreijl, C. F. The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. Cancer Lett., 130: 217-225, 1998.
57. Herrmann, C., Block, C., Geisen, C., Haas, K., Weber, C., Winde, G., Moroy, T., and Muller, O. Sulindac sulfide inhibits ras signaling. Oncogene, 17: 1769-1776, 1998.
58. Chinery, R., Beauchamp, R. D., Shyr, Y., Kirkland, S. C., Coffey, R. J., and Morrow, J. D. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res., 58: 2323-2327, 1998.
59. Michaluart, P., Masferrer, J. L., Carothers, A. M., Subbaramaiah, K., Zweifel, B. S., Koboldt, C., Mestre, J. R., Grunberger, D., Sacks, P. G., Tanabe, T., and Dannenberg, A. J. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res., 59: 2347-2352, 1999.
60. Tetsuka, T., Baier, L. D., and Morrison, A. D. Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric oxide synthase expression in rat mesangial cells: evidence for post-transcriptional regulation. J. Biol. Chem., 271: 11689-11693, 1996.
61. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., and Giardiello, F. M. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109: 994-998, 1995.
62. Rao, C. V., Desai, D., Simi, B., Kulkarni, N., Amin, S., and Reddy, B. S. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res., 53: 4182-4188, 1993.
63. Shiff, S. J., Qiao, L., Tsai, L. L., and Rigas, B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Investig., 96: 491-503, 1995.
64. Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L., and Matrisian, L. M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA, 94: 1402-1407, 1997.
65. Basson, M. D., Emenaker, N. J., and Rashid, Z. Effects of modulation of tyrosine phosphorylation on brush border enzyme activity in human Caco-2 intestinal epithelial cells. Cell Tissue Res., 292: 553-562, 1998.